1 Followers on Owler

ImmuneOncia

Read more
CEO Avatar

CEO

Yun Jeong Song

CEO Approval Rating

70/100

Founded:

2016

Status:

PrivateIndependent Company

Est. Annual Revenue
$1.5M
Agree?
Est. Employees
15
Agree?

ImmuneOncia News

ImmuneOncia Press Releases

Social Media

ImmuneOncia Headquarters

25, Tapsil-ro 35 road Giheung-gu

Yongin-si, Gyeonggido17084

82-31-306-8186

Driving Directions »

ImmuneOncia Summary

ABOUT

Overview

ImmuneOncia is a biopharmaceutical company that engages in researching and developing various immunotherapies for the treatment of cancer. ImmuneOncia was founded in 2016. ImmuneOncia's headquarters is located in Yongin-si, Gyeonggido, KR 17084. It ha...

CEO

ImmuneOncia's CEO, Yun Jeong Song, currently has an approval rating of 70%. ImmuneOncia's primary competitors are Peloton Therapeutics, Selecta & Blueprint Medicines Corp.

Acquisitions

There have been no acquisitions found related to ImmuneOncia

Investments

Recent investment data cannot be found related to ImmuneOncia

Frequently Asked Questions about ImmuneOncia

  1. When was ImmuneOncia founded?

    ImmuneOncia was founded in 2016
  2. Who is ImmuneOncia's CEO?

    ImmuneOncia's CEO is Yun Jeong Song
  3. How much revenue does ImmuneOncia generate?

    ImmuneOncia generates $1.5M in revenue
  4. How much funding does ImmuneOncia have?

    ImmuneOncia has historically raised $40M in funding
  1. Where is ImmuneOncia's headquarters?

    ImmuneOncia's headquarters is in Yongin-si Gyeonggido, KR
  2. How many employees does ImmuneOncia have?

    ImmuneOncia has 15 employees
  3. What sector does ImmuneOncia operate in?

    ImmuneOncia is in Biotechnology
  4. Who are ImmuneOncia's competitors?

    ImmuneOncia's top competitors are Peloton Therapeutics, Selecta, Blueprint Medicines Corp

Trending Companies